Loading organizations...
§ Venture Capital · Sanya, Hainan, China
Sunmed Capital functions as a venture capital firm with a clear focus on advancing medical device innovations. The firm dedicates its resources to identifying and supporting promising ventures within the healthcare technology landscape. It engages in collaborative efforts, working alongside physicians, engineers, and entrepreneurs, to foster the development and commercialization of new medical solutions.
Michael Wang serves as a Founding Partner for Sunmed Capital. His background includes prior experience as a Partner at bioVENTURE, highlighting a established pedigree in the specialized field of medical technology investment. The firm was established to address the critical need for dedicated capital and strategic guidance in the complex and rapidly evolving medical device sector.
The firm's primary beneficiaries are companies and innovators developing novel medical devices. Sunmed Capital aims to accelerate the progress of these enterprises, ultimately enhancing patient care and clinical outcomes. Its overarching vision is to be a catalyst for sustained innovation, propelling the medical device industry forward by nurturing the next generation of essential healthcare technologies.
Sunmed Capital has 1 tracked investment across 1 company. The latest tracked deal is $150.0M Series B in Noah Medical in April 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 20, 2023 | Noah Medical | $150.0M Series B | Prosperity7 Ventures, SoftBank Vision Fund | 1955 Capital, AME Cloud Ventures, Hillhouse Capital Group, Hongshan Capital Group (Sequoia Capital China), Lyfe Capital, ShangBay Capital, Tiger Global, UpHonest Capital |